Adult childhood cancer survivors of acute lymphoblastic leukemia, acute myeloid leukemia, and non-Hodgkin lymphoma frequently experience mental distress, fatigue, and executive function impairment. According to a study published online July 1, 2026, in Current Oncology, nearly half of surveyed participants met clinical thresholds for depression and anxiety, pointing to a distinct post-treatment care need.
Living through a cancer diagnosis in childhood changes the trajectory of a person’s life, but the physical and psychological toll does not necessarily stop when active treatment ends.
Conducted by Anna R. Franzén and colleagues at the Norwegian University of Science and Technology in Trondheim alongside two major Norwegian hospitals, the research tracked 132 participants to gauge how common these long-term effects truly are among individuals who beat cancer early in life.
Depression, Anxiety, and Fatigue Rates Among Leukemia and Lymphoma Survivors
The findings quantify what many survivors feel in daily life: high rates of psychological distress and persistent exhaustion. Researchers found that 49 percent of participants met the clinical thresholds for depression, while 41 percent met the clinical thresholds for anxiety.
Beyond mood disorders, physical and cognitive burdens weighed heavily on the cohort. Fatigue was reported by 43 percent of the adult survivors, and executive function impairment—affecting skills like planning, working memory, and flexible thinking—was documented in 28 percent of participants.
Statistical analysis from the team revealed a meaningful connection across these symptoms. Perceived executive function impairment showed a significant association with both mental distress and ongoing fatigue, suggesting that cognitive struggles and emotional exhaustion often travel together.
Global Context on Mental Health Disorders and Stigma
The Norwegian findings arrive against a backdrop of widespread mental health challenges globally. According to World Health Organization data, nearly 1 in 7 people worldwide lived with a mental disorder in 2021, totaling approximately 1.1 billion individuals, with anxiety and depressive disorders remaining the most common as detailed in agency fact sheets.
While effective psychological and pharmaceutical treatments exist for conditions ranging from generalized anxiety to major depression, access to adequate care remains limited for many. Patients frequently encounter systemic barriers, alongside the persistent weight of social stigma, discrimination, and human rights violations.
Intervention Strategies and Next Steps for Post-Treatment Care
The authors of the Norwegian study argue that routine survivorship care needs to expand beyond monitoring for cancer recurrence to actively target cognitive and psychological health.
As researchers look toward future clinical trials, the focus turns to whether targeted interventions for executive function can break the cycle between cognitive fatigue and psychological distress for aging survivors.
Related reading